Impact of medication adherence on hospitalization risk and healthcare cost

Department of Medical Affairs, Medco Health Solutions, Inc., Franklin Lakes, New Jersey 07417, USA.
Medical Care (Impact Factor: 2.94). 07/2005; 43(6):521-30. DOI: 10.1097/
Source: PubMed

ABSTRACT The objective of this study was to evaluate the impact of medication adherence on healthcare utilization and cost for 4 chronic conditions that are major drivers of drug spending: diabetes, hypertension, hypercholesterolemia, and congestive heart failure.
The authors conducted a retrospective cohort observation of patients who were continuously enrolled in medical and prescription benefit plans from June 1997 through May 1999. Patients were identified for disease-specific analysis based on claims for outpatient, emergency room, or inpatient services during the first 12 months of the study. Using an integrated analysis of administrative claims data, medical and drug utilization were measured during the 12-month period after patient identification. Medication adherence was defined by days' supply of maintenance medications for each condition.
The study consisted of a population-based sample of 137,277 patients under age 65.
Disease-related and all-cause medical costs, drug costs, and hospitalization risk were measured. Using regression analysis, these measures were modeled at varying levels of medication adherence.
For diabetes and hypercholesterolemia, a high level of medication adherence was associated with lower disease-related medical costs. For these conditions, higher medication costs were more than offset by medical cost reductions, producing a net reduction in overall healthcare costs. For diabetes, hypercholesterolemia, and hypertension, cost offsets were observed for all-cause medical costs at high levels of medication adherence. For all 4 conditions, hospitalization rates were significantly lower for patients with high medication adherence.
For some chronic conditions, increased drug utilization can provide a net economic return when it is driven by improved adherence with guidelines-based therapy.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Lack of adherence to anti diabetic medication causes suboptimal blood sugar control among patients with diabetes and can lead to treatment failures, accelerated development of complications and increased mortality. This study assessed factors associated with adherence to anti diabetic medication in rural eastern Uganda. A cross sectional study was conducted among 521 patients with diabetes in Iganga and Bugiri hospitals between October 2012 and January 2013. Respondents were patients who were18 years and above and had been on diabetic treatment for not less than a month. Pretested questionnaires were used. Variables that were collected included socio-demographic characteristics, possible barriers to adherence, and self management efforts. Adherence was assessed using self reports. Descriptive and inferential statistics were done to determine adherence to anti diabetic medication and the associated factors. The level of adherence to anti diabetic medication was 83.3% and factors that were independently associated with adherence were; having been on anti diabetic drugs for at least three years (OR = 1.89, 95% CI = 1.11 - 3.22), availability of diabetic drugs (OR = 2.59, 95% CI = 1.54 - 3.70), and having ever had diabetic health education (OR = 4.24, 95% CI =1.15 - 15.60). About four in five patients adhere to anti-diabetic treatment. Strategies aimed at improving anti diabetic drug availability and providing health education could improve adherence.
    BMC Health Services Research 04/2015; 15(1):168. DOI:10.1186/s12913-015-0820-5 · 1.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To evaluate the quality of existing value-based insurance design (V-BID) program evaluations on medication adherence, and to identify areas of expansion for future V-BID policy research. Study Design: Literature review. Methods: A structured search of the peer-reviewed literature was performed using healthcare and economic databases for studies evaluating the impact of V-BID programs on medication adherence. Characteristics of V-BID programs that may result in biased estimates for V-BID effectiveness were assessed and evaluated. Results: A total of 20 studies assessing the effects of 17 V-BID programs were identified. Medication adherence generally improved after V-BID implementation (mean effect size 3.4% after 1 year). The V-BID evaluation literature suffers from several methodological issues, such as a lack of reporting on baseline and final adherence rates, or absolute adherence changes. Factors that may influence observed effect sizes include program characteristics, baseline adherence rates, disease category, and disease management programs. Effect sizes were much higher in studies where the primary author reported employment by the study firm or sponsor. Conclusions: Many of the studies evaluating V-BID programs suffered from a lack of clarity when describing the methods used, or a lack of transparency when reporting results, and much of the evidence comes from studies where potential conflicts of interest exist. Authors should ensure that baseline and/or final adherence values are reported in addition to effect sizes, consistent terminology is used throughout a study, results are assessed for potential bias due to confounding factors, and due diligence has been performed to eliminate alternative explanations.
    American Journal of Managed Care 02/2015; 21(1):e78-e90.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the effectiveness of motivational interviewing (MI) in improving medication adherence in older patients being treated by polypharmacy. Cluster randomized clinical trial in 16 primary care centers with 27 health care providers and 154 patients. Thirty-two health care providers were assigned to an experimental (EG) or control group (CG). MI training program and review of patient treatments. Providers in the EG carried out MI, whereas those in the CG used an "advice approach". Three follow-up visits were completed, at 15 days and at 3 and 6 months. Medication adherence in both groups was compared (p<0.05). Patients recruited: 70/84 (EG/CG). Mean age: 76 years; female: 68.8%. The proportion of subjects changing to adherence was 7.6% higher in the EG (p<0.001). Therapeutic adherence was higher for patients in the EG (OR=2.84), women (OR=0.24) and those with high educational levels (OR=3.93). A face-to-face motivational approach in primary care helps elderly patients with chronic diseases who are being treated by polypharmacy to achieve an improved level of treatment adherence than traditional strategies of providing information and advice. MI is a patient-centered approach that can be used to improve medication adherence in primary care. This trial is registered at (NCT01291966). Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    Patient Education and Counseling 03/2015; DOI:10.1016/j.pec.2015.03.008 · 2.60 Impact Factor

Full-text (2 Sources)

Available from
Jun 4, 2014